← Back to Search

1 PEM for Breast Cancer

Phase 4
Waitlist Available
Led By Lorraine Tafra, MD
Research Sponsored by Naviscan PET Systems
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within the first 30 days (plus or minus 7 days) after surgery
Awards & highlights

Study Summary

Women with newly diagnosed breast cancer anticipating breast-conserving surgery are enrolled into the study and will undergo both high-resolution positron emission mammographic (PEM) imaging and contrast-enhanced magnetic resonance imaging (MRI) of the breast(s). The purpose of this study is to determine changes in surgical management resulting from PEM or MRI imaging as compared to conventional imaging and to determine if the changes were appropriate with histopathology as gold standard.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within the first 30 days (plus or minus 7 days) after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and within the first 30 days (plus or minus 7 days) after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The for this study will be measured by evidence of malignancy on PEM and/or MRI, confirmed by core biopsy or surgery.
Secondary outcome measures
Risk of false positive examinations with either PEM or MRI imaging with surgery as gold standard

Trial Design

2Treatment groups
Active Control
Group I: 1 PEMActive Control1 Intervention
Group II: 2 MRIActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Naviscan PET SystemsLead Sponsor
1 Previous Clinical Trials
22 Total Patients Enrolled
1 Trials studying Breast Cancer
22 Patients Enrolled for Breast Cancer
Certus International, Inc.OTHER
Lorraine Tafra, MDPrincipal InvestigatorAnne Arundel Medical Center, MD
1 Previous Clinical Trials
664 Total Patients Enrolled
1 Trials studying Breast Cancer
664 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study the Role of Positron Emission Mammography in Pre-surgical Planning for Breast Cancer
2006. "Study the Role of Positron Emission Mammography in Pre-surgical Planning for Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00484614.
All > Breast
~25 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top